Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial

A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion

(2017) Maurizio Zibetti et al.   JOURNAL OF NEUROLOGY

Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study

(2015) Kara M. Smith et al.   JAMA Neurology

Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson′s disease

(2014) Sanjib Sinha et al.   Annals of Indian Academy of Neurology

Negative influence of L-dopa on subjectively assessed sleep but not on nocturnal polysomnography in Parkinson's disease

(2014) Jakub M. Antczak et al.   Pharmacological Reports

Sleep and Circadian Rhythm Regulation in Early Parkinson Disease

(2014) David P. Breen et al.   JAMA Neurology

Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease

(2012) François Viallet et al.   CURRENT MEDICAL RESEARCH AND OPINION

Parkinson's disease sleep scale-validation of the revised version PDSS-2

(2011) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

2.240 RASAGILINE IMPROVES THE QUALITY OF SLEEP IN PATIENTS WITH PARKINSON'S DISEASE: RESULTS OF THE RASAGILINE EFFECT ON SLEEP TRIAL (REST)

(2011) M. Panisset et al.   PARKINSONISM & RELATED DISORDERS

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)

(2010) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

(2010) David A. Gallagher et al.   MOVEMENT DISORDERS

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

(2009) Paolo Barone et al.   MOVEMENT DISORDERS